410 Great Road
Amorsa is a preclinical stage, neuropharmaceutical company pioneering the development and commercialization of breakthrough treatments for nervous system disorders including treatment-resistant depression and moderate-to-severe pain. ? Founded in 2013, Amorsa has assembled a leadership team that helped build several life science companies and has a highly successful track record in developing novel therapeutic treatments. In addition, Amorsa has attracted leading neuroscience and pain management experts to join our Scientific and Clinical Advisory Board.
CEO and President: Joseph Blanchard
COO: Alex Nivorozhkin
CSO: Michael Palfreyman, DSc., PH.D.
Please click here for Amorsa's pipeline.
Please click here for Amorsa's technology.